BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7332914)

  • 21. [Clinical trial of the antibiotic Sisomycin].
    Mariani B; Mancini P
    G Ital Chemioter; 1977; 24(1-2):127-30. PubMed ID: 615756
    [No Abstract]   [Full Text] [Related]  

  • 22. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
    Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
    J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sisomicin sulfate: its efficacy in the treatment of urologic infections].
    Rodríquez Torres A
    Arch Esp Urol; 1979; 32(4):387-96. PubMed ID: 485572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of netilmicin-cefoxitin and gentamicin-cefoxitin in surgical patients with serious systemic infection.
    Bubrick MP; Howard RJ; Pancorbo S; Lorber RR; Chin TW; Yost R
    Clin Ther; 1983; 5(5):515-24. PubMed ID: 6352035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetics and clinical observations of sisomicin, a newly developed aminoglycoside derivative (author's transl)].
    Lode H; Kemmerich B; Koeppe P; Langmaack H
    Dtsch Med Wochenschr; 1975 Oct; 100(42):2144-50. PubMed ID: 1164890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental chemotherapeutic activity of sisomycin sulfate].
    Lobuseva AN; Fomina IP; Pozdniakova VP; Berezina EK; Ivanitskaia LP
    Antibiotiki; 1982 Nov; 27(11):835-9. PubMed ID: 7181467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sisomicin in surgical infections. Laboratory and clinical studies.
    Perea EJ; Gutierrez de la Pena C; Oliver DA; Solorzano G; Garcia-Diaz S
    Arzneimittelforschung; 1979; 29(1):134-7. PubMed ID: 375945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
    Eur J Surg Suppl; 1994; (573):61-6. PubMed ID: 7524798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sisomicin: a review of eight years' experience.
    Sanders WE; Sanders CC
    Rev Infect Dis; 1980; 2(2):182-95. PubMed ID: 6994206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Individualized monitoring of the therapy with gentamycin using pharmacokinetic methods. Which method to choose?].
    Carvalho A; Fonseca C; Falcão F; Pereira TA; Freitas O; Parrinha A; Costa M; Rodrigues MJ; Ceia F; Luís AS
    Acta Med Port; 1996; 9(7-9):187-95. PubMed ID: 9005695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fundamental and clinical studies on sisomicin in children (author's transl)].
    Iwai N; Sasaki A; Miyazu M; Osuga T
    Jpn J Antibiot; 1980 Mar; 33(3):333-51. PubMed ID: 6901786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased burn patient survival with individualized dosages of gentamicin.
    Zaske DE; Bootman JL; Solem LB; Strate RG
    Surgery; 1982 Feb; 91(2):142-9. PubMed ID: 7058491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical and bacteriological evaluation of sisomicin in sixteen cases of severe bronchopulmonary infection (author's transl)].
    Duwoos H; Carpentier P; Nouveau J; Guyonnaud CD; Abderhalden C
    Sem Hop; 1979 Nov 8-15; 55(37-38):1713-22. PubMed ID: 230590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Criteria for the selection of antibiotics in the empirical therapy of gram negative infections].
    Betts RF
    Internist (Berl); 1981 Nov; 22(11):710-4. PubMed ID: 7031008
    [No Abstract]   [Full Text] [Related]  

  • 36. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cefepime for infections of the biliary tract.
    Thompson JE; Bennion RS; Roettger R; Lally KP; Hopkins JA; Wilson SE
    Surg Gynecol Obstet; 1993; 177 Suppl():30-4; discussion 35-40. PubMed ID: 8256189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the therapeutic effectiveness and tolerability of sisomicin in the treatment of urinary tract infections].
    Dall'Aglio P; Nardoni N
    Clin Ter; 1980 Mar; 92(6):603-11. PubMed ID: 7460489
    [No Abstract]   [Full Text] [Related]  

  • 39. Tobramycin and gentamicin are equally safe for neonates: results of a double-blind randomized trial with quantitative assessment of renal function.
    Itsarayoungyuen S; Riff L; Schauf V; Hamilton L; Otrembiak J; Vidyasagar D
    Pediatr Pharmacol (New York); 1982; 2(2):143-55. PubMed ID: 12760406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective randomized study of two different doses of clindamycin admixed with gentamicin in the management of perforated appendicitis.
    Yellin AE; Berne TV; Heseltine PN; Appleman MD; Gill M; Chin A; Baker FJ
    Am Surg; 1993 Apr; 59(4):248-55. PubMed ID: 8489087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.